{
    "id": 80638,
    "name": "B-cell acute lymphoblastic leukemia",
    "source": "DOID",
    "definition": "An acute lymphocytic leukemia characterized by too many B-cell lymphoblasts (immature white blood cells) in the bone marrow and blood. []",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:0080638",
    "evidence": [
        
    ],
    "clinicalTrials": [
        {
            "nctId": "NCT02143414",
            "title": "Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia",
            "phase": "Phase II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 3194,
                    "therapyName": "Mercaptopurine + Methotrexate + Prednisone + Vincristine",
                    "synonyms": "POMP"
                },
                {
                    "id": 8573,
                    "therapyName": "Dasatinib + Prednisone",
                    "synonyms": null
                },
                {
                    "id": 8574,
                    "therapyName": "Blinatumomab + Dasatinib",
                    "synonyms": null
                },
                {
                    "id": 1876,
                    "therapyName": "Blinatumomab",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02535806",
            "title": "Four Drug Reinduction With Bortezomib for Relapsed or Refractory ALL or LL in Children and Young Adults",
            "phase": "Phase II",
            "recruitment": "Terminated",
            "therapies": [
                {
                    "id": 1631,
                    "therapyName": "Vincristine",
                    "synonyms": null
                },
                {
                    "id": 688,
                    "therapyName": "Bortezomib",
                    "synonyms": null
                },
                {
                    "id": 1638,
                    "therapyName": "Pegaspargase",
                    "synonyms": null
                },
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 712,
                    "therapyName": "Cytarabine",
                    "synonyms": null
                },
                {
                    "id": 1740,
                    "therapyName": "Mitoxantrone",
                    "synonyms": null
                },
                {
                    "id": 2188,
                    "therapyName": "Prednisone",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT02828358",
            "title": "Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement",
            "phase": "Phase II",
            "recruitment": "Suspended",
            "therapies": [
                {
                    "id": 8668,
                    "therapyName": "Cytarabine + Hydrocortisone + Leucovorin + Mercaptopurine + Pegaspargase",
                    "synonyms": null
                },
                {
                    "id": 8669,
                    "therapyName": "Cyclophosphamide + Cytarabine + Hydrocortisone + Mercaptopurine + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8666,
                    "therapyName": "Cytarabine + Hydrocortisone + Mercaptopurine + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 651,
                    "therapyName": "Azacitidine",
                    "synonyms": null
                },
                {
                    "id": 8667,
                    "therapyName": "Cytarabine + Daunorubicin + Dexamethasone + Hydrocortisone + Pegaspargase + Thioguanine + Vincristine sulfate liposome",
                    "synonyms": null
                },
                {
                    "id": 8670,
                    "therapyName": "Cytarabine + Daunorubicin + Dexamethasone + Hydrocortisone + Methotrexate + Pegaspargase + Prednisolone + Vincristine",
                    "synonyms": null
                },
                {
                    "id": 8664,
                    "therapyName": "Mercaptopurine + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 8665,
                    "therapyName": "Cyclophosphamide + Cytarabine + Thioguanine",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT03743246",
            "title": "A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B-cell Acute Lymphoblastic Leukemia (B-ALL) and B-cell Non-Hodgkin Lymphoma (B-NHL)",
            "phase": "Phase Ib/II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 9578,
                    "therapyName": "Cyclophosphamide + Fludarabine + JCAR017",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT04029038",
            "title": "Modified Immune Cells (CD19-CD22 CAR T Cells) in Treating Patients With Recurrent or Refractory CD19 Positive, CD22 Positive Leukemia or Lymphoma",
            "phase": "Phase Ib/II",
            "recruitment": "Not yet recruiting",
            "therapies": [
                {
                    "id": 9646,
                    "therapyName": "CD19/CD22 CAR T cells",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT04029688",
            "title": "A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Activity of Idasanutlin in Combination With Either Chemotherapy or Venetoclax in the Treatment of Pediatric and Young Adult Participants With Relapsed/Refractory Acute Leukemias or Solid Tumors",
            "phase": "Phase Ib/II",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 8616,
                    "therapyName": "Idasanutlin + Venetoclax",
                    "synonyms": null
                },
                {
                    "id": 8617,
                    "therapyName": "Cyclophosphamide + Idasanutlin + Topotecan",
                    "synonyms": null
                },
                {
                    "id": 8621,
                    "therapyName": "Cytarabine + Fludarabine + Idasanutlin",
                    "synonyms": null
                },
                {
                    "id": 8175,
                    "therapyName": "Cytarabine + Hydrocortisone + Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 712,
                    "therapyName": "Cytarabine",
                    "synonyms": null
                },
                {
                    "id": 1639,
                    "therapyName": "Methotrexate",
                    "synonyms": null
                },
                {
                    "id": 2023,
                    "therapyName": "Idasanutlin",
                    "synonyms": null
                },
                {
                    "id": 8626,
                    "therapyName": "Cyclophosphamide + Idasanutlin",
                    "synonyms": null
                }
            ]
        },
        {
            "nctId": "NCT04214886",
            "title": "CD19 Chimeric Antigen Receptor (CAR) T Cells for Adults With Recurrent or Refractory B Cell Malignancies",
            "phase": "Phase I",
            "recruitment": "Recruiting",
            "therapies": [
                {
                    "id": 9728,
                    "therapyName": "CD19-CD34 CAR transduced T cells + Cyclophosphamide + Fludarabine",
                    "synonyms": null
                }
            ]
        }
    ]
}